Treffer 1 - 6 von 6 für Suche 'Delnagro, Christopher', Suchdauer: 0,56s Treffer weiter einschränken
  1. 1
    Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18

    Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18 von Layman, Hans, Rickert, Keith W, Wilson, Susan, Aksyuk, Anastasia A, Dunty, Jill M, Natrakul, Dusit, Swaminathan, Nithya, DelNagro, Christopher J

    Veröffentlicht in PloS one

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    753 An open-label, phase 1a/b study of AB248, a CD8+ selective IL-2 mutein fusion protein, alone or in combination with pembrolizumab in patients with advanced solid tumors

    753 An open-label, phase 1a/b study of AB248, a CD8+ selective IL-2 mutein fusion protein, alone or in combination with pembrolizumab in patients with advanced solid tumors von Spigel, David R, Costantine Albany, Chisamore, Michael, Moynihan, Kelly D, DelNagro, Christopher, Visich, Jennifer, Axt, Matt, Liu, Xiaohan, Sayles, Mark, Pirzkall, Andrea, Buchbinder, Elizabeth I


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Abstract CT250: An open-label, phase 1a/b study of AB248, a CD8+ selective IL-2 mutein fusion protein, alone or in combination with pembrolizumab in patients with advanced solid tumors

    Abstract CT250: An open-label, phase 1a/b study of AB248, a CD8+ selective IL-2 mutein fusion protein, alone or in combination with pembrolizumab in patients with advanced solid tu... von Buchbinder, Elizabeth I., Spigel, David R., Albany, Costantine, Chisamore, Michael, Moynihan, Kelly D., Liu, Xiaohan, DelNagro, Christopher, Axt, Matt, Pirzkall, Andrea

    Veröffentlicht in Cancer research (Chicago, Ill.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI3185, a fully human antibody to CXCR4

    Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI3185, a fully human antibody to CXCR4 von Schwickart, Martin, Chavez, Carlos, Henderson, Simon, Vainshtein, Inna, Standifer, Nathan, DelNagro, Christopher, Mehrzai, Freshta, Schneider, Amy, Roskos, Lorin, Liang, Meina


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI 3185, a fully human antibody to CXCR 4

    Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI 3185, a fully human antibody to CXCR 4 von Schwickart, Martin, Chavez, Carlos, Henderson, Simon, Vainshtein, Inna, Standifer, Nathan, DelNagro, Christopher, Mehrzai, Freshta, Schneider, Amy, Roskos, Lorin, Liang, Meina


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  6. 6
    Abstract 964: Inhibiting glycolysis with an LDHA inhibitor: A new solution to an old problem

    Abstract 964: Inhibiting glycolysis with an LDHA inhibitor: A new solution to an old problem von O'Brien, Thomas, Purkey, Hans, Hitz, Anna, Peterson, Dave, Boudreau, Aaron, Delnagro, Christopher, Kwong, Mandy, Hong, Rebecca, Gao, Min, Pang, Jodi, Vanderbilt, Alex, Williams, Simon, Salphati, Laurent, Sampath, Deepak, Hatzivassiliou, Georgia, Evangelista, Marie

    Veröffentlicht in Cancer research (Chicago, Ill.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: